FIG. 5.
Improvement in clinical outcomes following dornase alfa treatment. Temporal changes of (a) Spo2 per patient, (b) respiratory rate per patient, (c) C-reactive protein per patient and (d) procalcitonin per patient.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.